Evaluation of sex hormone profile and semen parameters in acromegalic male patients von Yilmaz, M. K., Sulu, C., Ozkaya, H. M., Kadioglu, A., Ortac, M., Kadioglu, P.

Volltext

Initial treatment and survival in a national unselected Danish cohort of 4161 patients with pancreatic cancer von Rasmussen, L.S., Vittrup, B., Ladekarl, M., Pfeiffer, P., Yilmaz, M.K., Poulsen, L.Ø, Østerlind, K., Skuladottir, H., Hansen, C.P., Mortensen, M.B., Mortensen, F.V., Sall, M., Falkmer, U.G., Fristrup, C.

Volltext

NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metast... von Winther, S B, Skuladottir, H, Hofsli, E, Shah, C-H, Yilmaz, M K, Österlund, P J, Berglund, Å, Glimelius, B, Qvortrup, C, Sorbye, H, Pfeiffer, P

Volltext

Clinical utility of plasma cell-free DNA in patients with pancreatic cancer von Chen, I., Wind, K.L., Dehlendorff, C., Sørensen, B.S., Vittrup, B.V., Johansen, A., Pfeiffer, P., Bjerregaard, J.K., Bojesen, S.E., Nielsen, S.E., Holländer, N.H., Yilmaz, M.K., Rasmussen, L.S., Pallisgaard, N., Johansen, J.S., Spindler, K.-L.G.

Volltext

Venous thrombosis in pancreaticobiliary tract cancer: outcome and prognostic factors von Larsen, A. C., Brøndum Frøkjær, J., Wishwanath Iyer, V., Vincents Fisker, R., Sall, M., Yilmaz, M. K., Kuno Møller, B., Kristensen, S. R., Thorlacius‐Ussing, O.

Volltext

Clinical utility of serum type III collagen in patients with pancreatic carcinoma von Chen, I., Willumsen, N., Dehlendorff, C., Johansen, A., Vittrup, B.V., Krüger, M., Pfeiffer, P., Bjerregaard, J.K., Bojesen, S.E., Nielsen, S.E., Holländer, N.H., Yilmaz, M.K., Rasmussen, L.S., Karsdal, M., Johansen, J.S.

Volltext

Local recurrence rate in a national Danish patient cohort after curative treatment for rectal cancer von Poulsen, L Ø, Yilmaz, M K, Ljungmann, K, Jespersen, N, Wille-Jørgensen, P, Petersen, L N, Falkmer, U G

Volltext

A new perspective on the pleiotropic blood pressure improvement effect of sitagliptin: downregulation of miRNA-155 and miRNA-21 von Gul-Kahraman, M Yilmaz-Bozoglan K, Serhatlioglu, I, Onalan, E, Akkopru, M C, Sahna, E

Volltext

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorec... von MAGNE TVEIT, Kjell, GUREN, Tormod, FOKSTUEN, Tone, HANSEN, Flemming, HOFSLI, Eva, BIRKEMEYER, Elke, JOHNSSON, Anders, STARKHAMMAR, Hans, YILMAZ, Mette Karen, KELDSEN, Nina, BERIT ERDAL, Anne, DAJANI, Olav, GLIMELIUS, Bengt, DAHL, Olav, CHRISTOFFERSEN, Thoralf, PFEIFFER, Per, SORBYE, Halfdan, PYRHONEN, Seppo, SIGURDSSON, Fridbjorn, KURE, Elin, IKDAHL, Tone, SKOVLUND, Eva

Volltext

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch C... von van der Kruijssen, D. E.W, Elias, S. G, van de Ven, P. M, van Rooijen, K. L, Lam-Boer, J. ’t, Mol, L, Punt, C. J.A, Sommeijer, D. W, Tanis, P. J, Nielsen, J. D, Yilmaz, M. K, van Riel, J. M.G.H, Wasowiz-Kemps, D. K, Loosveld, O. J.L, van der Schelling, G. P, de Groot, J. W.B, van Westreenen, H. L, Jakobsen, H. L, Fromm, A. L, Hamberg, P, Verseveld, M, Jaensch, C, Liposits, G. I, van Duijvendijk, P, Oulad Hadj, J, van der Hoeven, J. A.B, Trajkovic, M, de Wilt, J. H.W, Koopman, M, van Grevenstein, W. M.U.Helma, CAIRO4 Working Group

Volltext

455PDNORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with m... von Winther, S B, Skuladottir, H, Hofsli, E, Shah, C-H, Yilmaz, M K, Österlund, P J, Berglund, Å, Glimelius, B, Qvortrup, C, Sorbye, H, Pfeiffer, P

Volltext

Green synthesis of substituted olefins (Heck Cross-Coupling Reaction) with palladium(II) catalysts bearing heterodonor P/N ligands von Yılmaz, Mustafa Kemal, İnce, Simay, Keleş, Mustafa, Güzel, Bilgehan

Volltext

Serum interleukin-6 as a prognostic biomarker for survival in patients with unresectable pancreatic cancer von Chen, I., Dehlendorff, C., Jensen, B.V., Pfeiffer, P., Nielsen, S.E., Holländer, N.H., Yilmaz, M.K., Johansen, J.

Volltext

743PInitial treatment and survival in a national unselected Danish cohort of 4161 patients with pancreatic cancer von Rasmussen, L S, Vittrup, B, Ladekarl, M, Pfeiffer, P, Yilmaz, M K, Poulsen, L Ø, Østerlind, K, Skuladottir, H, Hansen, C P, Mortensen, M B, Mortensen, F V, Sall, M, Falkmer, U G, Fristrup, C

Volltext

752PClinical utility of serum type III collagen in patients with pancreatic carcinoma von Chen, I, Willumsen, N, Dehlendorff, C, Johansen, A, Vittrup, B V, Krüger, M, Pfeiffer, P, Bjerregaard, J K, Bojesen, S E, Nielsen, S E, Holländer, N H, Yilmaz, M K, Rasmussen, L S, Karsdal, M, Johansen, J S

Volltext

Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan von Jensen, B.V., Spindler, K.-L.G., Christensen, I.J., Schou, J.V., Nielsen, D.L., Jakobsen, A., Høgdall, E., Pfeiffer, P., Yilmaz, M.K., Johansen, J.

Volltext

The role of risk factors on survival for patients with pancreatic cancer von Bagni, K., Dehlendorff, C., Jensen, B.V., Johansen, A.Z., Pfeiffer, P., Hansen, C.P., Nielsen, S.E., Yilmaz, M.K., Holländer, N.H., Johansen, J.

Volltext

Prognostic mRNA expression signatures in whole blood in patients with metastatic colorectal cancer treated with 3rd line cetuximab and irinotecan von Schou, J.V., Jensen, B.V., Nielsen, D.L., Palshof, J.A., Høgdall, E., Yilmaz, M.K., Pfeiffer, P., Johansen, J., Rossi, S.

Volltext

715PClinical utility of plasma cell-free DNA in patients with pancreatic cancer von Chen, I, Wind, K L, Dehlendorff, C, Sørensen, B S, Vittrup, B V, Johansen, A, Pfeiffer, P, Bjerregaard, J K, Bojesen, S E, Nielsen, S E, Holländer, N H, Yilmaz, M K, Rasmussen, L S, Pallisgaard, N, Johansen, J S, Spindler, K-L G

Volltext

Risk factors for brain metastases in patients with metastatic colorectal cancer von Christensen, T.D., Palshof, J.A., Larsen, F.O., Høgdall, E., Poulsen, T.S., Jensen, B.V., Pfeiffer, P., Yilmaz, M.K., Christensen, I.J., Nielsen, D.L.

Volltext